Diseases, Conditions, Syndromes

Review: cannabidiol may be beneficial for oral mucositis

(HealthDay)—Cannabidiol could be beneficial for the treatment of oral mucositis, although data on its use in dentistry are scarce, according to a review published online Feb. 12 in the Journal of Clinical Pharmacy and Therapeutics.

Medications

CVS generic competitor to EpiPen, sold at a 6th the price

CVS is now selling a rival, generic version of Mylan's EpiPen at about a sixth of its price, just months after the maker of the life-saving allergy treatment was eviscerated before Congress because of its soaring cost to ...

Obstetrics & gynaecology

Case report: Ustekinumab for Crohn's continued in pregnancy

(HealthDay)—Good outcome has been reported in a pregnant woman who continued ustekinumab (UST) therapy for Crohn's disease during pregnancy, according to a case report published online Dec. 22 in the Journal of Clinical ...

Medications

After harsh light, a cheaper version of EpiPen from Mylan

Mylan is releasing a generic version of its emergency allergy treatment EpiPen at half the price of the branded option, the cost of which drew scorn from parents nationwide and spawned Congressional inquiries.

Cardiology

Probable interaction ID'd for PrOD, ribavirin with warfarin

(HealthDay)—There is a probable interaction between paritaprevir/ritonavir/ombitasvir+dasabuvir (PrOD) plus ribavirin with warfarin, according to a case report published online Nov. 3 in the Journal of Clinical Pharmacy ...

Diseases, Conditions, Syndromes

Pharmacogenetic analyses can optimize clomipramine dosing

(HealthDay)—Pharmacogenetic analysis can help optimize clomipramine doses in patients who do not respond to standard-dose treatment, according to a report published online Oct. 31 in the Journal of Clinical Pharmacy and ...

Cardiology

Patient satisfaction up with pharmacist-managed warfarin Tx

(HealthDay)—Pharmacist-managed warfarin anticoagulation therapy is associated with improved patient satisfaction, although the benefits in terms of control, safety, and mortality are unclear, according to a review published ...

HIV & AIDS

Rapid, successful response to ART for many patients with HIV

(HealthDay)—Many HIV-infected patients have rapid and successful immune and virological response to antiretroviral therapy (ART), according to a study published online Sept. 27 in the Journal of Clinical Pharmacy and Therapeutics.

page 21 from 38